Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)
PHASE4
The purpose of the study is to study the combination of Sofosbuvir in Combi...
Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period
N/A
Using European data from patients included in the Named Patient Program (NP...
Status
Completed
Location
Local Institution
Start Date
2015-03
Trial ID
NCT02531269
Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults
N/A
The primary objective of the study is to determine the number of adverse ev...